ASG Eye Hospitals, one of India’s largest chains of specialised eye care facilities, is preparing to launch an initial public offering (IPO) targeting ₹500–600 crore. The proposed issue will primarily fund aggressive national expansion, new centre openings, technology upgrades, and working capital needs as the company aims to strengthen its leadership in the fast-growing Indian ophthalmology market.
Glimpse:
Announced on January 20, 2026, ASG Eye Hospitals plans to file its Draft Red Herring Prospectus (DRHP) with SEBI in the coming months. The IPO will consist of a fresh issue and an offer-for-sale component, with proceeds earmarked for establishing 50–60 new centres over the next 3–4 years, upgrading existing facilities with advanced diagnostic and surgical equipment, and strengthening its digital and tele-ophthalmology capabilities. The company currently operates 150+ centres across 12 states and is targeting significant market share growth in tier-2 and tier-3 cities.
ASG Eye Hospitals, India’s largest single-specialty eye care chain by number of centres, has formally disclosed its intention to pursue an initial public offering (IPO) in the range of ₹500–600 crore. The announcement, made during a media briefing on January 20, 2026, marks a major milestone for the Jaipur-headquartered company that has grown rapidly from a single clinic in 2005 to a network of more than 150 specialised eye hospitals and clinics spanning 12 states.
The proposed IPO will comprise a fresh issue of equity shares and an offer-for-sale (OFS) by existing shareholders. Proceeds from the fresh issue will primarily be utilised for:
Establishing 50–60 new centres across underserved tier-2 and tier-3 cities
Upgrading existing facilities with cutting-edge diagnostic tools (OCT, fundus cameras, perimetry), laser systems, and surgical platforms
Expanding tele-ophthalmology and digital health initiatives to reach remote areas
Investing in working capital and general corporate purposes
ASG’s current network serves more than 1.5 million patients annually, with strong presence in Rajasthan, Gujarat, Bihar, Jharkhand, Uttar Pradesh, Madhya Pradesh, West Bengal, Odisha, Chhattisgarh, and other states. The company has built its reputation on high-volume, affordable cataract surgeries, refractive procedures (LASIK, ICL), vitreoretinal services, glaucoma management, and paediatric ophthalmology.
Dr. Arun Singh, Founder & Managing Director of ASG Eye Hospitals, said: “The IPO is a natural next step in our journey to make world-class eye care accessible to every corner of India. The capital will allow us to accelerate our expansion into underserved regions, invest in the latest technology, and further strengthen our clinical outcomes and patient experience.”
The decision to go public comes at a time when India’s eye care market is growing rapidly, driven by an ageing population, increasing prevalence of diabetes-related retinopathy, rising awareness of refractive surgeries, and improving insurance penetration. ASG has already demonstrated strong operational metrics: high surgical volumes, consistent clinical outcomes, and a scalable hub-and-spoke model that balances super-specialty centres with outreach clinics.
Market observers note that the IPO will be closely watched as one of the first major listings in the single-specialty healthcare space in recent years. It follows a trend of healthtech and hospital chains pursuing public markets to fund growth amid strong investor appetite for quality healthcare franchises with proven unit economics.
The company has mandated leading investment banks to manage the issue and is targeting a listing on the BSE and NSE in the second half of 2026, subject to market conditions and regulatory approvals.
“Our vision has always been to bring advanced eye care to every Indian, regardless of geography or economic status. This IPO will give us the resources to turn that vision into reality at a much faster pace.”
By
HB Team
